Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest High-intensity focused ultrasound Stories

2013-06-03 08:27:51

Vacuum and broadband light treatment offers customized acne solution HAYWARD, Calif., June 3, 2013 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the global market leader in aesthetic skin treatments, today announced Isolaz(®) 2, the next generation acne therapy device. Isolaz 2 effectively targets the root causes of acne through a unique, clinically proven combination of vacuum extraction for deep pore purification, broadband light to destroy acne causing bacteria, and a...

2013-05-23 16:25:11

With Successful Launch of Sonatherm® HIFU Surgical Ablation System at AUA, SonaCare Medical Delivers on the Promise of Image Guided Minimally Invasive Technology SAN DIEGO, May 23, 2013 /PRNewswire/ -- The need to add tissue preserving therapies to the prostate cancer treatment continuum was highlighted prominently at the 108(th) Annual Meeting of the American Urological Association (AUA), in San Diego. According to SonaCare Medical, a leader in minimally invasive high intensity...

2013-05-06 08:30:06

Popular radiofrequency treatment provides early and, long-lasting results HAYWARD, Calif., May 6, 2013 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the global market leader in aesthetic skin treatments, today announced the Thermage(®) Total Tip 3.0, a highly effective treatment tip for face and neck as well as other body treatments that offers the earliest visible results in Thermage treatment history in addition to the consistent long-term results. Targeted, uniform, bulk...

2013-05-02 16:28:25

UCL's Mark Emberton, MD, to Direct Premier Training Center for the Use of Advanced Imaging Capabilities to Localize Cancer and Deliver HIFU Treatment Using Tissue Preserving Techniques CHARLOTTE, N.C., May 2, 2013 /PRNewswire/ -- SonaCare Medical, a global leader in minimally invasive HIFU technologies, announced today that it has partnered with University College London (UCL) to create a HIFU Center of Excellence. The Center of Excellence will provide physician training and...

2013-05-02 16:27:56

BOTHELL, Wash., May 2, 2013 /PRNewswire/ -- Today, at the 38th Annual Regional Anesthesiology and Acute Pain Medicine Meeting (ASRA), Alpinion Medical Systems (Booth #13) introduced the lightweight, highly portable E-Cube 7 ultrasound system for use in guidance during regional anesthesia and pain medicine procedures. The launch marks Alpinion's emergence into the U.S. market, following the company's success in the rest of the world. "With 2,000 systems installed worldwide, Alpinion is proud...

2013-05-02 12:28:48

Sonatherm is the Only Laparoscopic HIFU Device Cleared for Ablating Soft Tissue in the U.S. CHARLOTTE, N.C., May 2, 2013 /PRNewswire/ -- SonaCare Medical, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, announced today that it will launch the FDA-Cleared Sonatherm(®) HIFU Surgical Ablation System at the the 108(th) Annual Meeting of the American Urological Association (AUA), in San Diego, May 4-8, 2013 (booth #3611). A state-of-the-art...

2013-04-30 12:28:02

SmartTarget Offers a Clinically Tested and Practical Solution for MRI-Ultrasound Fusion CHARLOTTE, N.C. and LONDON, April 30, 2013 /PRNewswire/ -- SonaCare Medical, a global leader in minimally invasive High-Intensity Focused Ultrasound (HIFU) technologies, and UCL Business PLC (UCLB), a leading technology transfer company that supports and commercializes research and innovations from UCL (University College London), today announced a partnership to integrate SmartTarget image...

2013-04-25 15:43:53

Microbubbles decrease the time and acoustic power of ultrasound required to heat and destroy an embedded target, finds research in BioMed Central's open access journal Journal of Therapeutic Ultrasound. If these results can be replicated in the clinic, microbubbles could improve the efficiency of high intensity ultrasound treatment of solid tumors. High intensity ultrasound is already used to treat solid tumors. Ultrasound can be focused through soft tissue and, because it does not require...

2013-04-25 00:20:40

PMI initiates Transurethral Ultrasound Ablation (TULSA) clinical trial for novel, minimally invasive device for localized prostate cancer treatment  TORONTO, April 25, 2013 /PRNewswire/ - Profound Medical Inc. today announced the commencement of its Health Canada approved, multi-center TULSA (Transurethral Ultrasound Ablation) clinical trial for its minimally invasive, novel ablation device used to facilitate prostate cancer treatment. In the world's first procedure of its kind,...

2013-04-24 12:29:51

LONDON, ON, April 24, 2013 /PRNewswire/ - A world first procedure performed at London Health Sciences Center (LHSC) and facilitated by research at Lawson Health Research Institute (Lawson) provides a new minimally invasive treatment option for patients with localized prostate cancer. The treatment - transurethral magnetic resonance (MR) guided ultrasound ablation for prostate cancer - utilizes a new ablation device that uses thermal ultrasound therapy with real-time MR image guidance...